The venture arms of Sanofi and Astellas added cash to Avilar Therapeutics’ ‘ATAC’ mission. Medical Excellence Capital also joined the Big Pharma investment teams, along with original investor RA Capital. (Endpoints News)
The head of UNAids warned that Big Pharma must value African lives above profits. ‘Racist’ inequalities leave the sub-Saharan region bearing the burden of more than half the world’s new HIV infections, said Winnie Byanyima. (The Guardian)
West Pharmaceutical’s 2023 EPS guidance excluded the consensus estimate while its board approved a $1 billion share buyback. The company noted that currency translation negatively impacted net sales growth by 580 basis points. (Seeking Alpha)
Researchers said a pioneering diabetes drug offers hope for preventing autoimmune disorders. The approval of an antibody therapy that pauses the progression of type 1 diabetes is a first in the field, and some say a model for other drug developers. (Nature)
Elevance Health completed its acquisition of comprehensive specialty pharmacy BioPlus. Elevance says BioPlus will now operate as part of CarelonRx, Elevance’s pharmacy benefit manager within Carelon. (Inside Indiana Business)
